Business · 1 sources covering this

Symbiotec Pharmalab IPO GMP Points To 29% Listing Gain On Final Day Of Bidding

Symbiotec Pharmalab IPO GMP stood at Rs 285 on Day 4, indicating a potential 28.85% listing gain. Check subscription status, key dates and financials.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Symbiotec Pharmalab IPO GMP Points To 29% Listing Gain On Final Day Of Bidding
Symbiotec Pharmalab IPO GMP stood at Rs 285 on Day 4, indicating a potential 28.85% listing gain. Check subscription status, key dates and financials.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/59cee5e8d89c313f4cb801d1e01a784115bdf3fe"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Symbiotec Pharmalab IPO GMP Points To 29% Listing Gain On Final Day Of Bidding"></iframe>

Symbiotec Pharmalab IPO GMP Points To 29% Listing Gain On Final Day Of Bidding

How 1 sources are covering this

Symbiotec Pharmalab IPO GMP Points To 29% Listing Gain On Final Day Of Bidding

More from Business

10 years of UPI: How can it expand new frontiers for digital payments? | Explained

Govt proposes low-beam-only automatic headlamps for new two-wheelers

Nepal-Tibet flash flood: US vows $500,000 aid after ‘devastating floods’ claim 165+ lives, 63 US citizens missing

Toxic box office collection day 1: Yash film scores ₹100 Crore opening

Reader

Trust & legal

Across the network